美股市场个股详情
BPMC Blueprint Medicines
- 95.390
- +0.820+0.87%
收盘价 12/10 16:00 (美东)
- 94.000
- -1.390-1.46%
盘前 04:52 (美东)
60.60亿总市值-45641市盈率TTM
97.435最高价94.470最低价43.70万股成交量95.230今开94.570昨收4194.13万成交额0.70%换手率亏损市盈率(静)6352.58万总股本121.90052周最高19.35市净率59.95亿流通值72.24052周最低--股息TTM6284.51万流通股125.610历史最高--股息率TTM3.14%振幅13.040历史最低95.966平均价1股每手
关于Blueprint Medicines公司
蓝图医药公司是一家生物制药公司。它专注于改善由异常激酶激活引起的疾病患者的生活。该公司开发了针对癌症和罕见遗传病的小分子药物管线。其候选药物包括用于治疗系统性肥大细胞增多症的AYVAKIT，BLU-808，一种治疗肥大细胞疾病（包括慢性荨麻疹、睡眠中断和其他相关疾病）的潜在药物。该公司还有其他药物正在研发中，例如用于治疗乳腺癌的BLU-956、BLU-222。
公司介绍
公司代码BPMC
公司名称Blueprint Medicines
上市日期2015/04/30
发行价格18.00
成立日期2008
CEOMs. Kathryn Haviland
所属市场纳斯达克
员工数量655
年结日12-31
公司地址45 Sidney Street
城市Cambridge
省份马萨诸塞州
国家美国
邮编02139
电话1-617-374-7580
董事高管
- 姓名
- 职务
- 年薪
- Kathryn Haviland
- Director, President and Chief Executive Officer
- 643.20万
- Dr. Percy H. Carter, M.B.A.,PhD
- Chief Scientific Officer
- 229.98万
- Michael Landsittel, M.B.A.
- Chief Financial Officer
- 219.48万
- Dr. Christopher K. Murray, PhD
- Chief Technical Operations and Quality Officer
- --
- Tracey L. McCain, Esq.
- Chief Legal and Compliance Officer
- --
- Debra Durso-Bumpus
- Chief People Officer
- --
- Christina Rossi, M.B.A.
- Chief Operating Officer
- 280.62万
- Dr. Becker Hewes, M.D.
- Chief Medical Officer
- --
- Dr. Philina Lee, PhD
- Chief Commercial Officer
- --
- Ariel Hurley
- Senior Vice President, Finance and Principal Accounting Officer
- --
- Dr. Fouad Namouni, M.D.
- President, Research and Development
- 280.18万
- Jeffrey W. Albers, J.D.
- Chairman of the Board
- 52.61万
- Alexis A. Borisy, A.M.
- Director
- 39.73万
- Habib Joseph Dable
- Independent Director
- 41.23万
- Daniella Beckman
- Independent Director
- 42.23万
- Lonnel Coats
- Independent Director
- 41.93万
- Dr. Mark Alan Goldberg, M.D.
- Independent Director
- 41.93万
- Dr. Lynn Seely,M.D.
- Lead Independent Director
- 45.23万
- Dr. Nicholas Lydon, F.R.S.,PhD
- Independent Director
- 41.73万
- Dr. John Tsai, M.D.
- Independent Director
- 76.98万
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据
